One-year Outcomes in Survivors of the Severe COVID-19 Pneumonia (CO-Qo-ICU) (NCT04401111) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
One-year Outcomes in Survivors of the Severe COVID-19 Pneumonia (CO-Qo-ICU)
France90 participantsStarted 2020-06-16
Plain-language summary
Many of the patients hospitalized for a severe form of SARSCoV-2 respiratory impairment require prolonged intensive care that can be complicated in the short term, In the medium and long term, physical and psychological sequelae can affect patients' quality of life and prevent a return to normal working life.
To date, there is little data on the fate of patients treated in Resuscitation for a severe form of COVID-19, both in terms of respiratory sequelae, as well as in terms of psychological sequelae and their quality of life. The objective of this study is to be able to describe and evaluate the possible physical and psychological sequelae and quality of life of patients hospitalized in Resuscitation for a severe form of COVID-19 in the short (3 and 6 months), medium (1 year) and long (5 years) End of their stay in ICU. To do this, we want to carry out a prospective, observational and monocentric study in the consultation department of the Nice CHU. All patients admitted to Resuscitation for a severe form of COVID-19 who have accepted the longitudinal medical follow-up proposed by the Nice CHU will be included in the study and data from the computerized medical record will be analyzed.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients hospitalized in ICU for an ARDS table
* PCR SARSCoV-2 nasopharyngeal or positive pulmonary samples
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Since this study is observational and focused on tracking quality of life outcomes after severe COVID-19 and ARDS, rather than testing a new treatment, what does that mean for what my care team might learn from it that could apply to my situation?
2The trial is no longer actively recruiting patients — is there any way my experience or data could still contribute to research like this, or are there similar follow-up studies currently open that I might be eligible for?
3This study measures quality of life at three months after ICU care for severe COVID-19 pneumonia — based on what this research has found so far, what kinds of physical, mental, or cognitive challenges should I realistically be prepared for during my recovery?
4Given that this study focuses on people who had severe COVID-19 and ARDS requiring ICU care, are there specific rehabilitation programs or follow-up services that my doctor would recommend based on what studies like this one have revealed about long-term recovery?
5Since the study tracks outcomes over one year, what does the existing evidence from research like this suggest about how long recovery typically takes, and at what point should I be concerned if I'm not seeing improvement in my quality of life?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Quality of life assessment at 3 months of stay in ICU patients hospitalized for a severe form of COVID-19